Movatterモバイル変換


[0]ホーム

URL:


Skip to main content
Springer Nature Link
Log in

Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Paediatric Patients

Profile Report

  • Adis Profile Report
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content,log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association, 2000

    Google Scholar 

  2. Curran MP. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients. Pediatr Drugs 2011; 13 (3): 197–204

    Article  Google Scholar 

  3. Bristol-Myers Squibb. Abilify® (aripiprazole) tablets: US prescribing information [online]. Available from URL:http://www.abilify.com/pds/pi.aspx [Accessed 2011 Jan 10]

  4. Findling RL, Kauffman R, Sallee FR, et al. An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. J Child Adolesc Psychopharmacol 2009; 19 (4): 431–9

    Article PubMed  Google Scholar 

  5. Robb AS, Andersson C, Bellocchio EE, et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6–17 years old): results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011; 13 (1). pii: PCC. 10m01088

    Google Scholar 

  6. Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 2009; 69 (5): 535–48

    Article PubMed CAS  Google Scholar 

  7. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009 Dec; 124 (6): 1533–40

    Article PubMed  Google Scholar 

  8. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009 Nov; 48 (11): 1110–9

    Article PubMed  Google Scholar 

  9. Bristol-Myers Squibb. Final study report for study CN138180: a 52-week open-label multicenter study of the safety and tolerability of aripiprazole flexibly doses in the treatment of children and adolescents with austistic disorder [online]. Available from URL:http://www.clinicalstudyresults.org/documents/companystudy_8998_2.pdf [Accessed 2011 Jan 9]

Download references

Author information

Authors and Affiliations

  1. Adis, a Wolters Kluwer Business, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand

    Monique P. Curran

Authors
  1. Monique P. Curran

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMonique P. Curran.

Additional information

Adapted and reproduced from the original article published inPediatric Drugs 2011; 13 (3): 197-204.

Rights and permissions

About this article

Access this article

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

Advertisement


[8]ページ先頭

©2009-2025 Movatter.jp